...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO Investor Forum, Oct 22-23

....yes,,,estimates made by our dear n fearless team has historically proven they know not what is required for resources when it comes to trials,,,,,,I have a hard time finding any faith that they might evenĀ  accidentally meet an estimated completion date,,,and we all should know what faith gets us!!,,,,praying is just like talking to a wall!!,,pardon the pun,,,,!

,,,,but never say never,,I have been praying for a windfall for years,,and actually got several since I started praying!!,,all along the property boundry here,,,the trees have been uprooted ,,the last ones from hurricane Dorion,,,,,let that be written!,,,,I will assume the miss is because I forgot to put the word "investment" into the prayers...me bad,,,,,no matter,,,being the eternal optimist that I am....just maybe Big Pharma has lessoned our team and are responding accordingly,,,,,,,, :o)

Share
New Message
Please login to post a reply